Interfor Valuation

Is 8IF1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 8IF1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 8IF1 (€12.8) is trading below our estimate of fair value (€28.08)

Significantly Below Fair Value: 8IF1 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 8IF1?

Key metric: As 8IF1 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 8IF1. This is calculated by dividing 8IF1's market cap by their current revenue.
What is 8IF1's PS Ratio?
PS Ratio0.3x
SalesCA$3.06b
Market CapCA$986.37m

Price to Sales Ratio vs Peers

How does 8IF1's PS Ratio compare to its peers?

The above table shows the PS ratio for 8IF1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
DLX Delignit
0.3x10.2%€24.6m
STO3 Sto SE KGaA
0.4x1.8%€723.6m
ACT AlzChem Group
1.1x7.5%€606.5m
SZG Salzgitter
0.09x2.1%€942.2m
8IF1 Interfor
0.3x7.1%€986.4m

Price-To-Sales vs Peers: 8IF1 is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.5x).


Price to Sales Ratio vs Industry

How does 8IF1's PS Ratio compare vs other companies in the European Forestry Industry?

0 CompaniesPrice / SalesEstimated GrowthMarket Cap
8IF1 0.3xIndustry Avg. 0.7xNo. of Companies7PS00.40.81.21.62+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 8IF1 is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Forestry industry average (0.7x).


Price to Sales Ratio vs Fair Ratio

What is 8IF1's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

8IF1 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.2x

Price-To-Sales vs Fair Ratio: 8IF1 is expensive based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 8IF1 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€12.80
€17.19
+34.3%
10.8%€20.22€14.83n/a6
Nov ’25€12.30
€16.71
+35.8%
10.8%€20.05€14.70n/a6
Oct ’25€13.10
€15.25
+16.4%
10.0%€17.24€12.60n/a6
Sep ’25€10.90
€15.25
+39.9%
10.0%€17.24€12.60n/a6
Aug ’25€11.80
€15.38
+30.4%
13.0%€17.39€12.04n/a6
Jul ’25€10.90
€17.63
+61.8%
9.7%€20.34€14.92n/a6
Jun ’25€11.70
€17.63
+50.7%
9.7%€20.34€14.92n/a6
May ’25€11.60
€18.49
+59.4%
7.8%€20.41€16.33n/a6
Apr ’25€14.40
€19.27
+33.8%
7.7%€20.64€17.20n/a6
Mar ’25€13.40
€19.27
+43.8%
7.7%€20.64€17.20n/a6
Feb ’25€13.90
€20.16
+45.0%
5.1%€21.87€18.45n/a6
Jan ’25€15.60
€19.20
+23.1%
10.1%€21.79€16.34n/a5
Dec ’24€13.70
€19.20
+40.2%
10.1%€21.79€16.34n/a5
Nov ’24€11.50
€19.48
+69.4%
9.1%€21.95€17.15€12.305
Oct ’24€13.90
€23.82
+71.3%
11.5%€28.55€20.89€13.105
Sep ’24€15.20
€23.35
+53.6%
10.8%€27.83€21.04€10.905
Aug ’24€15.90
€23.46
+47.6%
10.4%€27.80€21.02€11.805
Jul ’24€17.10
€23.14
+35.3%
12.2%€28.46€20.13€10.906
Jun ’24€13.50
€21.81
+61.5%
15.4%€27.91€16.48€11.707
May ’24€13.90
€21.97
+58.0%
15.6%€27.75€16.38€11.607
Apr ’24€14.10
€22.62
+60.4%
14.7%€28.20€16.65€14.407
Mar ’24€15.20
€23.90
+57.2%
18.8%€31.47€16.92€13.407
Feb ’24€17.90
€23.14
+29.2%
20.0%€30.99€16.66€13.907
Jan ’24€14.70
€24.43
+66.2%
20.9%€31.82€16.74€15.607
Dec ’23€18.40
€27.42
+49.0%
14.0%€33.05€22.99€13.706
Nov ’23€17.80
€29.60
+66.3%
12.8%€34.18€23.78€11.506

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies